Ascendis Pharma A/S vs Dicks Sporting Goods Inc — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Dicks Sporting Goods Inc trades at $206.29 (market cap $18.35B). The key difference: Ascendis Pharma A/S and Dicks Sporting Goods Inc are close in size by market cap, and Dicks Sporting Goods Inc pays a 2.44% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | DKS | |
|---|---|---|
Market Cap | $16.67B | $18.35B |
Sector | Health | Consumer Cyclical |
52-Week High | $277.18 | $239.17 |
52-Week Low | $189.74 | $187.78 |
Enterprise Value | $17.04B | $25.14B |
Dividend Yield | — | 2.44% |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →